Prazosin Hydrochloride
Product Images NDC 43353-035

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Prazosin Hydrochloride (NDC 43353-035). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 2mg (43353 035)

Bottle Label 2mg (43353 035)
Label for Prazosin Hydrochloride 2 mg capsules, containing 90 capsules. Label shows storage instructions and indicates the product is repackaged by Aphena Pharma Solutions - Tennessee, Inc. Manufacturer is Teva Pharmaceuticals USA, Sellersville, PA. The label includes barcodes and space for batch, expiration, and lot information, marked RX only.*
FDA Label Image

Prazosin Hydrochloride Capsules Structural Formula (722b7796 Becb 4bd0 Ad66 Ef8a4d7ff7b9)

Prazosin Hydrochloride Capsules Structural Formula (722b7796 Becb 4bd0 Ad66 Ef8a4d7ff7b9)
Chemical structure diagram of Prazosin Hydrochloride, showing its molecular arrangement including methoxy groups, amine, piperazine ring, and a furan ring with carbonyl, along with the hydrochloride salt indication.*
FDA Label Image

Aphena Pharma Solutions (TN)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.